Zum Hauptinhalt springen

Showing 1–3 of 3 results for author: Wason, J

Searching in archive cs. Search in all archives.
.
  1. arXiv:2408.04677  [pdf, other

    cs.RO eess.SY

    Open-Source Software Architecture for Multi-Robot Wire Arc Additive Manufacturing (WAAM)

    Authors: Honglu He, Chen-lung Lu, Jinhan Ren, Joni Dhar, Glenn Saunders, John Wason, Johnson Samuel, Agung Julius, John T. Wen

    Abstract: Wire Arc Additive Manufacturing (WAAM) is a metal 3D printing technology that deposits molten metal wire on a substrate to form desired geometries. Articulated robot arms are commonly used in WAAM to produce complex geometric shapes. However, they mostly rely on proprietary robot and weld control software that limits process tuning and customization, incorporation of third-party sensors, implement… ▽ More

    Submitted 7 August, 2024; originally announced August 2024.

  2. arXiv:2404.06687  [pdf, other

    cs.RO eess.SY

    Fast and Accurate Relative Motion Tracking for Dual Industrial Robots

    Authors: Honglu He, Chen-lung Lu, Glenn Saunders, Pinghai Yang, Jeffrey Schoonover, Leo Ajdelsztajn, John Wason, Santiago Paternain, Agung Julius, John T. Wen

    Abstract: Industrial robotic applications such as spraying, welding, and additive manufacturing frequently require fast, accurate, and uniform motion along a 3D spatial curve. To increase process throughput, some manufacturers propose a dual-robot setup to overcome the speed limitation of a single robot. Industrial robot motion is programmed through waypoints connected by motion primitives (Cartesian linear… ▽ More

    Submitted 14 August, 2024; v1 submitted 9 April, 2024; originally announced April 2024.

  3. arXiv:2004.12028  [pdf, other

    stat.ME cs.LG q-bio.QM stat.ML

    Two-Stage Penalized Regression Screening to Detect Biomarker-Treatment Interactions in Randomized Clinical Trials

    Authors: Jixiong Wang, Ashish Patel, James M. S. Wason, Paul J. Newcombe

    Abstract: High-dimensional biomarkers such as genomics are increasingly being measured in randomized clinical trials. Consequently, there is a growing interest in developing methods that improve the power to detect biomarker-treatment interactions. We adapt recently proposed two-stage interaction detecting procedures in the setting of randomized clinical trials. We also propose a new stage 1 multivariate sc… ▽ More

    Submitted 28 April, 2021; v1 submitted 24 April, 2020; originally announced April 2020.

    Comments: Accepted version, to be published in Biometrics